Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e738b817ba73fc072e6dab0c96b6b567 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 |
filingDate |
2020-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3c4b1d8c16ba84f2d873de6cae576c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5d2280ca6a83a4a2e1ac7995b680cf8 |
publicationDate |
2021-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2021113161-A |
titleOfInvention |
Lesch-Nyhan Syndrome Remedy |
abstract |
PROBLEM TO BE SOLVED: To provide a therapeutic agent for Lesch-Nyhan syndrome acting on nerve cells. SOLUTION: A therapeutic agent for Lesch-Nyhan syndrome containing a xanthine oxidoreductase inhibitor having no purine skeleton as an active ingredient. [Selection diagram] None |
priorityDate |
2020-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |